Uploaded June 2026 | Updated September 2026, 2 weeks ago
#shorts #cannabisresearch #cannabistesting Dr. Kristofer Marsh is the Chief Scientific Officer of Smithers Cannabis Testing Services Division, as well the State Director for Smithers’ New York laboratory. He has over 9 years of experience in the Cannabis testing industry spanning operations in 11 U.S. states and is a member of the Cannabis Science Section with the American Council of Independent Laboratories (ACIL).
At CannMed 26, Kris presented “Pyrocannabinoids: An investigation into smoked cannabinoid isolates”
During our conversation, we discuss:
* What pyrocannabinoids are and how they're formed
* Why THCA, CBD, and THCV isolates were chosen as the focus of the study
* What new cannabinoids were created after those isolates were combusted
* How this change in cannabinoids raises questions about the entourage effect in smoked versus ingested cannabis
* Next steps for pyrocannabinoid research
Thanks to This Episode's Sponsor: Cannabis Chemistry Subdivision of the American Chemical Society (CANN)
Since 2015, CANN has been building a strong network of scientists in the cannabis space to promote scientific innovation, safety, and development through education, research, and the empowerment of the scientific community. To learn more about what CANN has to offer please visit their website at www.cann-acs.org.
#shorts #cannabisresearch #cannabistesting Dr. Kristofer Marsh is the Chief Scientific Officer of Smithers Cannabis Testing Services Division, as well the State Director for Smithers’ New York laboratory. He has over 9 years of experience in the Cannabis testing industry spanning operations in 11 U.S. states and is a member of the Cannabis Science Section with the American Council of Independent Laboratories (ACIL).
At CannMed 26, Kris presented “Pyrocannabinoids: An investigation into smoked cannabinoid isolates”
During our conversation, we discuss:
* What pyrocannabinoids are and how they're formed
* Why THCA, CBD, and THCV isolates were chosen as the focus of the study
* What new cannabinoids were created after those isolates were combusted
* How this change in cannabinoids raises questions about the entourage effect in smoked versus ingested cannabis
* Next steps for pyrocannabinoid research
Thanks to This Episode's Sponsor: Cannabis Chemistry Subdivision of the American Chemical Society (CANN)
Since 2015, CANN has been building a strong network of scientists in the cannabis space to promote scientific innovation, safety, and development through education, research, and the empowerment of the scientific community. To learn more about what CANN has to offer please visit their website at www.cann-acs.org.





![Breeding for Better Solventless Extraction with Alisha Holloway, PhD
Alisha Holloway is the Chief Scientific Officer at Phylos where she leads the R&D group that focuses on foundational genomic research, development of high-throughput genetic and chemical testing capabilities, discovery of genetic markers, and the development of new cannabis varieties via classical and marker-assisted breeding.
At CannMed 26, she will present “Enhancing Cannabis Quality via Marker-Assisted Selection for Improved Solventless Extraction Yield”
During our conversation, we discuss:
* What solventless extraction is and why its gaining popularity
* The traits that make a cannabis plant a good washer
* How Alisha’s team designed and conducted a washability study across hundreds of plant samples
* How they identified genetic markers for good washers that hold up across diverse genetic backgrounds
* How marker-assisted selection accelerates the breeding process
Thanks to This Episodes Sponsor: The Cannabis Research Center & Coalition.
The Cannabis Research Center & Coalition (CRC), founded by Dr. Allison Justice, is a professional group dedicated to advancing cannabis cultivation and post harvest processing. CRC partners with Universities and The Hemp Mine LLC, an industry leader in cannabis genetics and production, to tackle the cultivation and post harvest challenges facing today’s cannabis industry.
Their cooperative research model, inspired by successful horticulture and greenhouse research collaborations, allows members to benefit from pooled resources, gaining access to cutting-edge, science-based research at a fraction of the cost.
Learn more at cannabisrc.org
Additional Resources
* Phylos - https://phylos.bio/
* Instagram - https://www.instagram.com/phylosbio/
* Linkedin - https://www.linkedin.com/company/phylosbio
* [Blog] What Makes a Cannabis Variety “Wash Well”? The Science Behind High-Yield Hash Plants - https://phylos.bio/blog/cannabis-washability-genetics
* https://www.instagram.com/shwale/
* Register for CannMed 26 - https://cannmedevents.com/package-options/
* Meet the CannMed 26 Speakers - https://cannmedevents.com/speakers/
* Review the Podcast - https://podcasts.apple.com/us/podcast/cannmed-coffee-talk/id1504218804
* CannMed Archive - https://cannmedevents.com/cannmed-video-archives/ Breeding for Better Solventless Extraction with Alisha Holloway, PhD](https://i.ytimg.com/vi/yTmycWnOfHE/mqdefault.jpg)
![What is Cannabinoid Hyperemesis Syndrome & Why Has Researching it been so difficult? - Codi Peterson
Dr. Codi Peterson is a pediatric pharmacist with over a decade of experience specializing in acute care and pediatric emergency medicine. He currently serves as a clinical pharmacist at Radys Childrens Health of Orange County, where he works night shifts in the Emergency Department and applies his expertise to optimize medication safety and therapeutic outcomes in children. Beyond the hospital, Codi is deeply committed to education and mentorship. He is an Associate Clinical Professor at the University of California, Irvine, where he teaches cannabis pharmacology and therapeutics, and a guest lecturer at OCEMT, instructing paramedics and firefighters in applied pharmacology.
He is also an active researcher on Cannabinoid Hyperemesis Syndrome (CHS), having led one of the largest patient surveys on the condition to date. At CannMed 26, Codi will share the results of that study in a presentation titled, “Through the Eyes of a Patient: Integrating Story and Science to Demystify CHS”.
During our conversation, we discuss:
- Defining CHS and explaining why it is difficult to research
- Cannabis use patterns among CHS sufferers
- Whether contaminants and pesticides play a role in developing CHS
- The prodromal phase and early warning signs of CHS
- Sex-based differences in CHS patients
- Understanding the biological mechanisms behind the development of CHS
- and more
Thanks to This Episodes Sponsor: The Cannigma
The Cannigma takes an evidence-based approach to cannabis content – from safety to cooking to medical research – and makes all the information digestible and useful.
They are committed to making sure scientific information is accessible to anyone who needs it – be it to relieve their own suffering or that of a loved one, to learn a bit more, or even just for fun.
Learn more at cannigma.com
Additional Resources
- Surveying Cannabinoid Hyperemesis Syndrome Patients with Megan Mbengue and Codi Peterson [Video] - https://youtu.be/ez7PyEESrSU
- Cannabinoid Hyperemesis Syndrome What You Need to Know [Video] - https://youtu.be/9hCp6puJvXc?si=Gc14ELLhC3S5KOBL
- what-is-chs.com
- Codi on IG - https://www.instagram.com/cannabispharmd/
- Codi on LinkedIn - https://www.linkedin.com/in/cannapharmd/
- The Cannigma - cannigma.com
- Register for CannMed 26 - Early Bird Ends February 20th! - https://cannmedevents.com/package-options/ What is Cannabinoid Hyperemesis Syndrome & Why Has Researching it been so difficult? - Codi Peterson](https://i.ytimg.com/vi/ykNUSCa1d14/mqdefault.jpg)


